A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide(®)) to the innovator brand in critically ill patients

INTRODUCTION: Clinicians’ skepticism, fueled by evidence of inferiority of some multisource generic antimicrobial products, results in the underutilization of more cost-effective generics, especially in critically ill patients. The aim of this observational study was to demonstrate equivalence betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mer, Mervyn, Snyman, Jacques Rene, van Rensburg, Constance Elizabeth Jansen, van Tonder, Jacob John, Laurens, Ilze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117905/
https://www.ncbi.nlm.nih.gov/pubmed/27895516
http://dx.doi.org/10.2147/CPAA.S106676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117905/
https://www.ncbi.nlm.nih.gov/pubmed/27895516
http://dx.doi.org/10.2147/CPAA.S106676

Ejemplares similares